Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Stem Cell Reconstructive Market

ID: MRFR/LS/0487-HCR
110 Pages
Satyendra Maurya
Last Updated: April 15, 2026

์ค„๊ธฐ ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์กฐ์‚ฌ ๋ณด๊ณ ์„œ ์ •๋ณด ์ถœ์ฒ˜(๋™์ข…, ์ž๊ฐ€, ๋™๊ณ„ ๋ฐ ๊ธฐํƒ€), ์„ธํฌ ์œ ํ˜•(๋ฐฐ์•„ ์ค„๊ธฐ ์„ธํฌ, ์„ฑ์ฒด ์ค„๊ธฐ ์„ธํฌ), ์šฉ๋„(์•”, ๋‹น๋‡จ๋ณ‘, ์™ธ์ƒ์„ฑ ํ”ผ๋ถ€ ๊ฒฐํ•จ, ์‹ฌํ•œ ํ™”์ƒ), ์ตœ์ข… ์‚ฌ์šฉ์ž(๋ณ‘์›, ์—ฐ๊ตฌ ๊ธฐ๊ด€)๋ณ„ ์ •๋ณด - 2032๋…„๊นŒ์ง€ ์˜ˆ์ธก

๊ณต์œ 
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Stem Cell Reconstructive Market Infographic
Purchase Options
  1. 1 ์„œ๋ก 
    1. 1.1 ์ •์˜
    2. 1.2 ์—ฐ๊ตฌ ๋ฒ”์œ„
      1. 1.2.1 ์—ฐ๊ตฌ ๋ชฉํ‘œ
      2. 1.2.2 ๊ฐ€์ • ๋ฐ ์ œํ•œ ์‚ฌํ•ญ
        1. 1.2.2.1 ๊ฐ€์ •
        2. 1.2.2.2 ์ œํ•œ ์‚ฌํ•ญ
    3. 1.3 ์‹œ์žฅ ๊ตฌ์กฐ
  2. 2 ์—ฐ๊ตฌ ๋ฐฉ๋ฒ•๋ก 
    1. 2.1 ์—ฐ๊ตฌ ํ”„๋กœ์„ธ์Šค:
    2. 2.2 1์ฐจ ์—ฐ๊ตฌ
    3. 2.3 2์ฐจ ์—ฐ๊ตฌ:
  3. 3 ์‹œ์žฅ ์—ญํ•™
    1. 3.1 ๋™์ธ
    2. 3.2 ์ œ์•ฝ
    3. 3.3 ๊ธฐํšŒ
    4. 3.4 ๊ฑฐ์‹œ ๊ฒฝ์ œ ์ง€ํ‘œ
  4. 4 ์‹œ์žฅ ์š”์ธ ๋ถ„์„
    1. 4.1 ํฌํ„ฐ์˜ 5๊ฐ€์ง€ ํž˜ ๋ชจ๋ธ
    2. 4.2 ๊ณต๊ธ‰์ž์˜ ํ˜‘์ƒ๋ ฅ
    3. 4.3 ๊ตฌ๋งค์ž์˜ ํ˜‘์ƒ๋ ฅ
    4. 4.4 ์‹ ๊ทœ ์ง„์ž…์ž์˜ ์œ„ํ˜‘ ์ง„์ž…์ž
    5. 4.5 ๋Œ€์ฒด์žฌ์˜ ์œ„ํ˜‘
    6. 4.6 ๊ฒฝ์Ÿ์˜ ๊ฐ•๋„
  5. 5 ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„
    1. 5.1 ๋™์ข… ์ค„๊ธฐ์„ธํฌ
    2. 5.2 ์ž๊ฐ€ ์ค„๊ธฐ์„ธํฌ
      1. 5.2.1 ๊ณจ์ˆ˜
      2. 5.2.2 ์ง€๋ฐฉ ์กฐ์ง
      3. 5.2.3 ํ˜ˆ์•ก
    3. 5.3 ๋™์ข… ์ค„๊ธฐ์„ธํฌ
    4. 5.4 ๊ธฐํƒ€
  6. 6 ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„
    1. 6.1 ๋ฐฐ์•„ ์ค„๊ธฐ์„ธํฌ
    2. 6.2 ์„ฑ์ฒด ์ค„๊ธฐ์„ธํฌ
  7. 7 ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„
    1. 7.1 ์•”
    2. 7.2 ๋‹น๋‡จ๋ณ‘
    3. 7.3 ์™ธ์ƒ์„ฑ ํ”ผ๋ถ€ ๊ฒฐํ•จ
    4. 7.4 ์‹ฌํ•œ ํ™”์ƒ
    5. 7.5 ๊ธฐํƒ€
  8. 8 ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„
    1. 8.1 ๋ณ‘์›
    2. 8.2 ์—ฐ๊ตฌ์†Œ
    3. 8.3 ๊ธฐํƒ€
  9. 9 ์ง€์—ญ๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ
    1. 9.1 ์„œ๋ก 
    2. 9.2 ๋ฏธ๊ตญ
      1. 9.2.1 ๋ถ๋ฏธ
        1. 9.2.1.1 ๋ฏธ๊ตญ
        2. 9.2.1.2 ์บ๋‚˜๋‹ค
      2. 9.2.2 ๋‚จ๋ฏธ
    3. 9.3 ์œ ๋Ÿฝ
      1. 9.3.1 ์„œ์œ ๋Ÿฝ
        1. 9.3.1.1 ๋…์ผ
        2. 9.3.1.2 ํ”„๋ž‘์Šค
        3. 9.3.1.3 ์ดํƒˆ๋ฆฌ์•„
        4. 9.3.1.3 ์ŠคํŽ˜์ธ
        5. 9.3.1.5 ์˜๊ตญ
        6. 9.3.1.6 ๊ธฐํƒ€ ์„œ์œ ๋Ÿฝ ์ง€์—ญ
      2. 9.3.2 ๋™์œ ๋Ÿฝ
    4. 9.4 ์•„์‹œ์•„ ํƒœํ‰์–‘
      1. 9.4.1 ์ผ๋ณธ
      2. 9.4.2 ์ค‘๊ตญ
      3. 9.4.3 ์ธ๋„
      4. 9.4.4 ํ˜ธ์ฃผ
      5. 9.4.5 ๋Œ€ํ•œ๋ฏผ๊ตญ
      6. 9.4.6 ์•„์‹œ์•„ ํƒœํ‰์–‘์˜ ๋‚˜๋จธ์ง€ ์ง€์—ญ
    5. 9.5 ์ค‘๋™ ๋ฐ ์•„ํ”„๋ฆฌ์นด
      1. 9.5.1 ์•„๋ž์—๋ฏธ๋ฆฌํŠธ
      2. 9.5.2 ์‚ฌ์šฐ๋””์•„๋ผ๋น„์•„
      3. 9.5.3 ์˜ค๋งŒ
      4. 9.5.4 ์ฟ ์›จ์ดํŠธ
      5. 9.5.5 ์นดํƒ€๋ฅด
      6. 9.5.6 ์ค‘๋™ ๋ฐ ์•„ํ”„๋ฆฌ์นด์˜ ๋‚˜๋จธ์ง€ ์ง€์—ญ
  10. 10 ๊ฒฝ์Ÿ ํ™˜๊ฒฝ
    1. 10.1 ์‹œ์žฅ ์ฐธ์—ฌ์ž๋“ค์ด ์ฑ„ํƒํ•œ ์ฃผ์š” ์ „๋žต
      1. 10.1.1 ์ „๋žต์  ํŒŒํŠธ๋„ˆ์‹ญ
      2. 10.1.2 ํ•ฉ๋ณ‘ ๋ฐ ์ธ์ˆ˜
  11. 11 ํšŒ์‚ฌ ํ”„๋กœํ•„
    1. 11.1 CYTORI THERAPEUTICS INC
      1. 11.1.1 ๊ฐœ์š”
      2. 11.1.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.1.3 ์žฌ๋ฌด
      4. 11.1.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    2. 11.2 ELEVEFLOW
      1. 11.2.1 ๊ฐœ์š”
      2. 11.2.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.2.3 ์žฌ๋ฌด
      4. 11.2.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    3. 11.3 MICRONIT MICROFLUIDICS
      1. 11.3.1 ๊ฐœ์š”
      2. 11.3.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.3.3 ์žฌ๋ฌด
      4. 11.3.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    4. 11.4 CYNATA ์น˜๋ฃŒ์ œ
      1. 11.4.1 ๊ฐœ์š”
      2. 11.4.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.4.3 ์žฌ๋ฌด
      4. 11.4.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    5. 11.5 ์…€๋ฆฌ์•„๋“œ
      1. 11.5.1 ๊ฐœ์š”
      2. 11.5.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.5.3 ์žฌ๋ฌด
      4. 11.5.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    6. 11.6 ๋ฐ•์Šคํ„ฐ
      1. 11.6.1 ๊ฐœ์š”
      2. 11.6.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.6.3 ์žฌ๋ฌด
      4. 11.6.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    7. 11.7 ๋ฉ”์†Œ๋ธ”๋ผ์ŠคํŠธ LTD
      1. 11.7.1 ๊ฐœ์š”
      2. 11.7.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.7.3 ์žฌ๋ฌด
      4. 11.7.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    8. 11.8 NUVASIVE INC
      1. 11.8.1 ๊ฐœ์š”
      2. 11.8.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.8.3 ์žฌ๋ฌด
      4. 11.8.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    9. 11.9 OSIRIS
      1. 11.9.1 ๊ฐœ์š”
      2. 11.9.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.9.3 ์žฌ๋ฌด
      4. 11.9.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    10. 11.10 PFIZER INC
      1. 11.10.1 ๊ฐœ์š”
      2. 11.10.2 ์ œํ’ˆ ๊ฐœ์š”
      3. 11.10.3 ์žฌ๋ฌด
      4. 11.10.4 ์ฃผ์š” ๊ฐœ๋ฐœ
    11. 11.11 ๊ธฐํƒ€
  12. 12 ๊ฒฐ๋ก 
    1. 13.1 ์ฃผ์š” ๊ฒฐ๊ณผ
      1. 13.1.1 CEO ๊ด€์ ์—์„œ
      2. 13.1.2 ์‹œ์žฅ์˜ ์ถฉ์กฑ๋˜์ง€ ์•Š์€ ์š”๊ตฌ ์‚ฌํ•ญ
    2. 13.2 ์ฃผ๋ชฉํ•ด์•ผ ํ•  ์ฃผ์š” ํšŒ์‚ฌ
    3. 13.3 ์ƒ๋ช… ๊ณผํ•™ ์‚ฐ์—…์— ๋Œ€ํ•œ ์˜ˆ์ธก
  13. 14 ๋ถ€๋ก
    1. ํ‘œ ๋ชฉ๋ก
    2. ํ‘œ 1 ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‚ฐ์—… ๊ฐœ์š”, 2020-2027
    3. ํ‘œ 2 ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ถ”์ •์น˜ ๋ฐ ์˜ˆ์ธก, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    4. ํ‘œ 3 ์ง€์—ญ๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    5. ํ‘œ 4 ์ถœ์ฒ˜๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    6. ํ‘œ 5 ์„ธํฌ ์œ ํ˜•๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    7. ํ‘œ 6 ์‘์šฉ ํ”„๋กœ๊ทธ๋žจ๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    8. ํ‘œ 7 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    9. ํ‘œ 8 ์ถœ์ฒ˜๋ณ„ ๋ถ๋ฏธ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    10. ํ‘œ 9 ๋ถ๋ฏธ ์ค„๊ธฐ์„ธํฌ ์„ธํฌ ์œ ํ˜•๋ณ„ ์žฌ๊ฑด ์‹œ์žฅ, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    11. ํ‘œ 10 ๋ถ๋ฏธ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    12. ํ‘œ 11 ๋ถ๋ฏธ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    13. ํ‘œ 12 ๋ฏธ๊ตญ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    14. ํ‘œ 13 ๋ฏธ๊ตญ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    15. ํ‘œ 14 ๋ฏธ๊ตญ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    16. ํ‘œ 15 ๋ฏธ๊ตญ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    17. ํ‘œ 16 ์บ๋‚˜๋‹ค ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    18. ํ‘œ 17 ์บ๋‚˜๋‹ค ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    19. ํ‘œ 18 ์บ๋‚˜๋‹ค ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    20. ํ‘œ 19 ์บ๋‚˜๋‹ค ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    21. ํ‘œ 20 ๋‚จ๋ฏธ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    22. ํ‘œ 21 ๋‚จ๋ฏธ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    23. ํ‘œ 22 ๋‚จ๋ถ€ ๋ฏธ๊ตญ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    24. ํ‘œ 23 ๋‚จ๋ฏธ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    25. ํ‘œ 24 ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    26. ํ‘œ 25 ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    27. ํ‘œ 26 ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    28. ํ‘œ 27 ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    29. ํ‘œ 28 ์„œ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    30. ํ‘œ 29 ์„œ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    31. ํ‘œ 30 ์„œ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    32. ํ‘œ 31 ์„œ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    33. ํ‘œ 32 ๋™์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    34. ํ‘œ 33 ๋™์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    35. ํ‘œ 34 ๋™์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    36. ํ‘œ 35 ๋™์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    37. ํ‘œ 36 ์•„์‹œ์•„ ํƒœํ‰์–‘ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    38. ํ‘œ 37 ์•„์‹œ์•„ ํƒœํ‰์–‘ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    39. ํ‘œ 38 ์•„์‹œ์•„ ํƒœํ‰์–‘ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    40. ํ‘œ 39 ์•„์‹œ์•„ ํƒœํ‰์–‘ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    41. ํ‘œ 40 ์ค‘๋™ ๋ฐ ์•„ํ”„๋ฆฌ์นด ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ถœ์ฒ˜๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    42. ํ‘œ 41 ์ค‘๋™ ๋ฐ ์•„ํ”„๋ฆฌ์นด ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์„ธํฌ ์œ ํ˜•๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    43. ํ‘œ 42 ์ค‘๋™ ๋ฐ ์•„ํ”„๋ฆฌ์นด ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์‘์šฉ ๋ถ„์•ผ๋ณ„, 2020-2027๋…„, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)
    44. ํ‘œ 43 ์ค‘๋™ ๋ฐ ์•„ํ”„๋ฆฌ์นด ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ, ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„, 2020-2027, (๋ฐฑ๋งŒ ๋‹ฌ๋Ÿฌ)?
    45. ?
    46. ๊ทธ๋ฆผ ๋ชฉ๋ก
    47. ๊ทธ๋ฆผ 1 ์—ฐ๊ตฌ ํ”„๋กœ์„ธ์Šค
    48. ๊ทธ๋ฆผ 2 ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์„ธ๋ถ„ํ™”
    49. ๊ทธ๋ฆผ 3 ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์„ธ๋ถ„ํ™” ์‹œ์žฅ ์—ญํ•™
    50. ๊ทธ๋ฆผ 4 ์ถœ์ฒ˜๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ 2020
    51. ๊ทธ๋ฆผ 5 ์„ธํฌ ์œ ํ˜•๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ 2020
    52. ๊ทธ๋ฆผ 6 ์‘์šฉ ๋ถ„์•ผ๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ 2020
    53. ๊ทธ๋ฆผ 7 ์ตœ์ข… ์‚ฌ์šฉ์ž๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ, 2020
    54. ๊ทธ๋ฆผ 8 ์ง€์—ญ๋ณ„ ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ, 2020
    55. ๊ทธ๋ฆผ 9 ๊ตญ๊ฐ€๋ณ„ ๋ถ๋ฏธ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ 2020
    56. ๊ทธ๋ฆผ 10 ๊ตญ๊ฐ€๋ณ„ ์œ ๋Ÿฝ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ, 2020
    57. ๊ทธ๋ฆผ 11 ๊ตญ๊ฐ€๋ณ„ ์•„์‹œ์•„ ํƒœํ‰์–‘ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ, 2020
    58. ๊ทธ๋ฆผ 12 ๊ตญ๊ฐ€๋ณ„ ์ค‘๋™ ๋ฐ ์•„ํ”„๋ฆฌ์นด ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ ์ ์œ ์œจ, 2020
    59. ๊ทธ๋ฆผ 13 ๊ธ€๋กœ๋ฒŒ ์ค„๊ธฐ์„ธํฌ ์žฌ๊ฑด ์‹œ์žฅ: ๊ธฐ์—… ์ ์œ ์œจ ๋ถ„์„, 2020(%)
Case Study Cover Image
์‚ฌ๋ก€ ์—ฐ๊ตฌ

Aerospace & Defense

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization โœ“ โœ“ โœ“
Direct Access to Analyst โœ“ โœ“ โœ“
Deliverable Format โœ“ โœ“ โœ“
Platform Access โœ— โœ— โœ“
Discount on Next Purchase 10% 15% 15%
Printable Versions โœ— โœ— โœ“